“Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus”
This study, published in Journal of Antimicrobial Chemotherapy (2012), identifies capsaicin as an effective inhibitor of the NorA efflux pump, reducing the invasion of Staphylococcus aureus. The research was co-authored by NP Kalia and others.
“Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection”
Published in Proceedings of the National Academy of Sciences (2017), this paper investigates how targeting the synthetic lethality of terminal respiratory oxidases can clear Mycobacterium tuberculosis infections, offering potential therapeutic strategies.
“Sulfur-rich 2-mercaptobenzothiazole and 1, 2, 3-triazole conjugates as novel antitubercular agents”
This article in the European Journal of Medicinal Chemistry (2014) discusses the synthesis and antitubercular properties of sulfur-rich conjugates, with NP Kalia contributing to the study.
“Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors”
A 2008 publication in Bioorganic & Medicinal Chemistry, which presents piperine analogs as inhibitors of the NorA efflux pump in Staphylococcus aureus, a key player in antibiotic resistance.
“Protective efficacy of piperine against Mycobacterium tuberculosis”
In this 2014 Tuberculosis journal article, the protective effect of piperine against Mycobacterium tuberculosis is evaluated, with NP Kalia contributing to the study.
“Piperine as an inhibitor of the MdeA efflux pump of Staphylococcus aureus”
Published in Journal of Medical Microbiology (2011), this study explores the potential of piperine to inhibit the MdeA efflux pump, which is involved in antibiotic resistance in Staphylococcus aureus.
“Antimicrobial and Antimycobacterial Activities of Methyl Caffeate Isolated from Solanum torvum Swartz. Fruit”
In this 2012 Indian Journal of Microbiology article, methyl caffeate isolated from Solanum torvum fruit is evaluated for its antimicrobial and antimycobacterial properties.
“Dual inhibition of the terminal oxidases eradicates antibioticātolerant Mycobacterium tuberculosis”
A study in EMBO Molecular Medicine (2021), where the dual inhibition of terminal oxidases is shown to eradicate antibiotic-tolerant Mycobacterium tuberculosis.